HOME >> BIOLOGY >> NEWS
UC Davis wins new national center for avian flu research

ight it with preventive vaccines and antiviral drugs.

UC Davis' chief role in the new surveillance and research center will be to coordinate the collection and testing of tens of thousands of samples from wildlife, especially wild birds, on both the U.S. and Asian sides of the Pacific Ocean.

UC Davis will also collect samples, in collaboration with the University of Alaska, Fairbanks (UAF), and the Wildlife Conservation Society.

UC Davis will sample wildlife in the Pacific Flyway from California to Alaska. UAF will sample in Alaska, Far East Russia and Japan. The Wildlife Conservation Society, based in New York City, will sample in Cambodia, Laos and Mongolia.

All samples will be tested at UC Davis and UAF for the presence of influenza viruses. Positive samples will then be sent to Layne's group at UCLA for precise identification based on their genetic makeup.

Layne will direct the High Speed High Volume Laboratory Network for Infectious Diseases, which is being created to quickly analyze and process high quantities of biological samples. It will have the unique capability to analyze influenza genes from thousands of viruses each year, far more quickly and in far greater numbers than any other program.

The final CRISAR collaborator, Los Alamos National Laboratory, will provide technological support to UCLA's high-speed laboratory and create dipstick test devices for identifying positive flu samples in the field.

"Clearly it's important to know if and when strains of flu like Asian H5N1 make it to the U.S. But we can't stop there," said Boyce. "We need to know how viruses are changing, and whether they are becoming more or less of a threat.

"This new national influenza surveillance and research center gives us that ability. CRISAR and the other NIH centers will work together to reduce and manage the threat of influenza."

The Cali
'"/>

Contact: Walter Boyce
wmboyce@ucdavis.edu
530-752-1401
University of California - Davis
2-Apr-2007


Page: 1 2 3

Related biology news :

1. UC Davis is partner in new $125 million federal bioenergy research center
2. UC Davis study finds high arsenic levels in herbal kelp supplements
3. UC Davis researchers use heated nanoprobes to destroy breast cancer cells in mice
4. UC Davis researchers discover key to bodys ability to detect subtle temperature changes
5. APS names UC Davis professor Bodil Schmidt-Nielsen Distinguished Mentor and Scientist
6. UC Davis scientists groundbreaking research: Mate-attracting chemicals
7. UC Davis breast cancer researchers report new insights into ductal carcinoma in situ
8. British cattle give TB to badgers, finds UC Davis expert
9. UC Davis study finds distinct genetic profiles
10. UC Davis researchers move biotechnology closer to replacing electronic pacemakers
11. UC Davis study finds brain cell regulator is volume control, not on/off switch

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Davis wins new national center for avian flu research

(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
(Date:10/15/2014)... Alt will be awarded the 44th Rosenstiel Award for ... his pioneering research exploring the mechanisms of genomic instability ... cells. Alt is the second alumnus to win the ... Prize in 2003. , Alt is the Charles A. ... Harvard Medical School and an investigator at the Howard ...
(Date:10/14/2014)... N.Y. – Scientists have sequenced the house fly genome ... one might expect from an insect that thrives in ... published Oct. 14 in the journal Genome Biology ... biology and of how flies quickly adapt to resist ... Adult house flies (Musca domestica) carry and transmit more ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech ... company tackling big healthcare problems, announced today the ... round, with participation from Invesco Perpetual, a $120 ... used to drive PureTech,s existing pipeline forward and ... "PureTech has the scientific creativity to really go ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: